News

Keep up to date with our latest announcements.

December 5, 2024
New

Interna Therapeutics Reports on an Ongoing Phase I Clinical Trial of an Intranasal COVID-19 Drug
December 2, 2024
New

Interna Therapeutics will be attending the J.P. Morgan 43rd Annual Healthcare Conference on January 13-16, 2025, in San Francisco, CA, USA

November 11, 2024
New

Interna Therapeutics announces that it will present at the upcoming Investival Showcase conference on November 18, 2024, in London, UK

November 4, 2024
New

Aposense Ltd. Secures $10.25 Million Funding Round; Announces Merger with SirVir and name change to “Interna Therapeutics”
April 6, 2024

Aposense gives a short talk at the Delivery of Nucleic Acid Therapeutics II: Biology, Engineering and Development conference in Siracusa, Sicily, Italy, Apr 4-8, 2024